The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2009, 182, 4728 -4736
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0803892

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zimmerli, C.
Right arrow Articles by Imhof, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zimmerli, C.
Right arrow Articles by Imhof, B. A.

Adaptive Immune Response in JAM-C-Deficient Mice: Normal Initiation but Reduced IgG Memory1

Claudia Zimmerli*, Boris P. L. Lee*, Gaby Palmer*,{dagger}, Cem Gabay*,{dagger}, Ralf Adams{ddagger}, Michel Aurrand-Lions2,* and Beat A. Imhof3,*

* Department of Pathology and Immunology, University of Geneva School of Medicine, Geneva, Switzerland; {dagger} Division of Rheumatology, Department of Internal Medicine, University Hospital, Geneva, Switzerland and Department of Pathology and Immunology, University of Geneva School of Medicine, Geneva, Switzerland; {ddagger} Max Planck Institute for Molecular Biomedecine, Department of Tissue Morphogenesis, Münster, Germany

We have recently shown that junctional adhesion molecule (JAM)-C-deficient mice have leukocytic pulmonary infiltrates, disturbed neutrophil homeostasis, and increased postnatal mortality. This phenotype was partially rescued when mice were housed in ventilated isolators, suggesting an inability to cope with opportunistic infections. In the present study, we further examined the adaptive immune responses in JAM-C–/– mice. We found that murine conventional dendritic cells express in addition to Mac-1 and CD11c also JAM-B as ligand for JAM-C. By in vitro adhesion assay, we show that murine DCs can interact with recombinant JAM-C via Mac-1. However, this interaction does not seem to be necessary for dendritic cell migration and function in vivo, even though JAM-C is highly expressed by lymphatic sinuses of lymph nodes. Nevertheless, upon immunization and boosting with a protein Ag, JAM-C-deficient mice showed decreased persistence of specific circulating Abs although the initial response was normal. Such a phenotype has also been observed in a model of Ag-induced arthritis, showing that specific IgG2a Ab titers are reduced in the serum of JAM-C–/– compared with wild-type mice. Taken together, these data suggest that JAM-C deficiency affects the adaptive humoral immune response against pathogens, in addition to the innate immune system.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by grants from the Swiss National Science Foundation (310000-120184/1) and the Swiss Cancer League (OCS-01653-02-2005) (to B.A.I.).

2 Current address: UMR891, Inserm, Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, 27, bd Leï Roure, Marseille, France.

3 Address correspondence and reprint requests to: Prof. Beat Imhof, Universite de Geneve, 1 rue Michel Servet, Geneva, Switzerland. E-mail address: Beat.Imhof{at}unige.ch

4 Abbreviations used in this paper: JAM, junctional adhesion molecule; DC, dendritic cell; WT, wild type; BM-DC, bone-marrow derived DC; NP-CGG, chicken {gamma}-globulin; TNCB, 2,4,6-trinitrochlorobenzene; mBSA, methylated BSA; pDC, plasmacytoid DC; cDC, conventional DC; CHS, contact hypersensitivity; AIA, Ag-induced arthritis; 7-AAD, 7-aminoactinomycin D; GC, germinal center; FDC, follicular dendritic cell; LYVE, lymphatic vessel endothelial receptor; CMTMR, 5- and 6-(((4-chloromethyl)benzoyl)amino)tetramethylrhodamine.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.